Detection of the WT1 transcript by RT-PCR in complete remission has no prognostic relevance in de novo acute myeloid leukemia (original) (raw)

Clinical Laboratory Correlates

Leukemia volume 12, pages 1886–1894 (1998)Cite this article

Abstract

The WT1 gene is expressed in 73–100% of patients with acute myelogenous leukemia (AML) and is thought to play a role in maintaining the viability of leukemic cells. WT1 has been proposed as a marker for minimal residual disease in leukemia. We obtained serial blood or bone marrow samples from patients with de novo AML at diagnosis, during therapy, and up to 95 months after diagnosis and analyzed for WT1 gene expression by RT-PCR to determine whether gene expression was predictive of relapse. Forty-four patients had WT1-positive AML and achieved a complete remission (CR) following chemotherapy and 24 patients underwent unrelated donor (n = 4), sibling donor (n = 13) or autologous (n = 7) marrow transplantation. After achieving CR 62% of the patients became WT1-negative, while 38% remained WT1-positive. There was no difference in the disease-free survival (DFS) and survival from remission between WT1-positive and -negative patients (P > 0.1). Following BMT, 32% of the patients analyzed in CR within the first 100 days after transplantation were WT1 PCR positive. Detection of WT1 transcripts within 100 days following BMT did not affect DFS and overall survival (OS) after transplantation (P > 0.1). Ten of 11 patients who are in continuous CR following chemotherapy or BMT for more than 3 years were transiently WT1-positive during the observation period. Four of these patients displayed the WT1 transcript at the last examination. Thirteen of 39 patients were WT1 PCR negative within 4 months before clinical onset of relapse and eight patients were WT1 PCR negative at time of relapse. These data indicate that: (1) achievement of WT1 negativity is not associated with longer DFS, survival from remission, or OS after transplantation; (2) not all patients who relapse become WT1 positive again; (3) long-term remitters frequently display the WT1 transcript. Thus, we conclude that the monitoring of WT1 gene expression by qualitative RT-PCR during treatment and CR is of very limited value.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$259.00 per year

only $21.58 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

Author information

Authors and Affiliations

  1. First Department of Medicine, Division of Hematology, University of Vienna, Vienna, Austria
    A Gaiger, D Schmid, B Linnerth, K Tisljar, S Priglinger, K Laczika, M Mitterbauer, M Novak, K Lechner & U Jäger
  2. Department of Medical Computer Sciences, University of Vienna, Vienna, Austria
    G Heinze
  3. First Department of Medicine, Bone Marrow Transplantation, University of Vienna, Vienna, Austria
    H Greinix & P Kalhs
  4. Department of Laboratory Medicine, University of Vienna, Vienna, Austria
    G Mitterbauer & C Mannhalter
  5. St Anna Kinderspital, Vienna, Austria
    OA Haas

Authors

  1. A Gaiger
    You can also search for this author inPubMed Google Scholar
  2. D Schmid
    You can also search for this author inPubMed Google Scholar
  3. G Heinze
    You can also search for this author inPubMed Google Scholar
  4. B Linnerth
    You can also search for this author inPubMed Google Scholar
  5. H Greinix
    You can also search for this author inPubMed Google Scholar
  6. P Kalhs
    You can also search for this author inPubMed Google Scholar
  7. K Tisljar
    You can also search for this author inPubMed Google Scholar
  8. S Priglinger
    You can also search for this author inPubMed Google Scholar
  9. K Laczika
    You can also search for this author inPubMed Google Scholar
  10. M Mitterbauer
    You can also search for this author inPubMed Google Scholar
  11. M Novak
    You can also search for this author inPubMed Google Scholar
  12. G Mitterbauer
    You can also search for this author inPubMed Google Scholar
  13. C Mannhalter
    You can also search for this author inPubMed Google Scholar
  14. OA Haas
    You can also search for this author inPubMed Google Scholar
  15. K Lechner
    You can also search for this author inPubMed Google Scholar
  16. U Jäger
    You can also search for this author inPubMed Google Scholar

Rights and permissions

About this article

Cite this article

Gaiger, A., Schmid, D., Heinze, G. et al. Detection of the WT1 transcript by RT-PCR in complete remission has no prognostic relevance in de novo acute myeloid leukemia.Leukemia 12, 1886–1894 (1998). https://doi.org/10.1038/sj.leu.2401213

Download citation

Keywords

This article is cited by